Shankar Ramaswamy, MD

Co-Founder, Chief Executive Officer, and Chairman

Shankar Ramaswamy is the Co-Founder, Chairman, and Chief Executive Officer of Kriya Therapeutics. Previously, Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, where he was responsible for identifying and evaluating assets across multiple therapeutic areas and launching its first public subsidiary company. He went on to be the Chief Business Officer of Axovant Gene Therapies (now Sio Gene Therapies).

Dr. Ramaswamy received his Medical Degree from Brown University and his undergraduate degree in Economics from Harvard University.